Zydus Lifesciences Ltd signed a licensing agreement with Daewoong Pharmaceutical Co Ltd of South Korea on Monday to co-develop and commercialize a generic version of Leuprolide Acetate for depot suspension, which is used to treat advanced...
PNB VESPER, a Kochi-based research-based biopharmaceutical company, has signed agreements with the National Institute on Drug Abuse (NIDA), the lead federal agency supporting scientific research on drug abuse and addiction disorders, to develop...
As per Astellas Pharma US, Inc. Cresemba (isavuconazonium sulfate), an azole antifungal medication, has been approved by the US Food and medication Administration (FDA) for the treatment of invasive aspergillosis (IA) and invasive mucormycosis...
Sanofi and Minapharm have announced the signing of an exclusive Manufacturing and Supply Agreement for the localization of the entire Clexane product line. The agreement between Sanofi, a global pharmaceutical company and Egypt's Minapharm...
Babson Diagnostics, a science-first health care technology business, announced that a key component of its BetterWay Blood Testing ecosystem has received FDA 510(k) clearance. These regulatory approvals open the way for Babson to launch BetterWay...
The U.S Food and Drug Administration (FDA) approved two gene therapies for sickle cell disease, including the first treatment in the country based on the Nobel Prize-winning CRISPR gene editing technique. Casgevy, developed by partners Vertex...
Immunotherapy works on the principle that the ability of the body and the immune system to recognize and eliminate cancer cells. One of the most promising tools in this regard is immune response inhibitors.
Bayer Pharmaceuticals Division in India has launched its engaging "#ReadyToSlowDown" campaign in collaboration with the Indian Society of Nephrology to encourage Indians to adopt a kidney-conscious lifestyle. "#ReadyToSlowDown" campaign is an...
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company, today announced an expansion of its licensing agreement with Synaffix B.V., a Lonza company focused on commercializing its clinical-stage platform technology for the...
The World Health Organization (WHO) has issued its first-ever guidelines on managing chronic low back pain (LBP) in primary and community care settings, outlining which therapies to utilize and which to avoid during regular care. Low back pain is...
, CDSCO.jpg)
